SaaS MVP Development · Raleigh, NC

SaaS MVP development in Raleigh.

Raleigh-Durham builds companies the Triangle way: spinouts carrying university IP, SBIR-funded ventures mapping grants to milestones, and B2B products sold to the most hype-resistant technical buyers in the Southeast. MVPs here win on substance, documentation, and pilots designed for institutional calendars.

We build SaaS MVPs end to end: Next.js and TypeScript on Postgres, repository structures that respect licensed IP, grant-milestone-aligned phases, real trial paths, and production deployment. You own the code, cleanly.

How we work

Tell us the product, the funding shape, and the first pilot.

The technical reality of shipping an MVP in the Triangle.

Spinout hygiene is repository hygiene: licensed methods separated from original product code, IP boundaries respected in structure rather than memory, and a cap table the next investor's counsel reads without questions. The harder spinout question is the market one, and we push it early: the product needs a buyer beyond the founding lab.

SBIR funding maps naturally to fixed-scope phases: workplan objectives become named deliverables, decision logs become progress-report material, and demos land on reporting deadlines. Grant scope and product scope get tracked as the overlapping-but-different things they are.

The Triangle buyer rewards the unscripted question: working trials, first-class documentation, visible methodology behind every number, and integrations that respect the incumbent stack. The MVP ships with a real trial path and docs treated as product surface, because that is how this market evaluates.

Local pilots are won on friction math: department-approvable pricing, no-IT-ticket onboarding, written success criteria, and a forwardable readout. University labs add the academic calendar and citation-friendly outputs to the brief, and both are worth engineering for.

What an MVP engagement includes.

The standard build, tuned for Triangle ventures.

Core workflow, end to end

Next.js, TypeScript, Postgres. The essential loop built completely, with a self-serve trial path as first-class scope.

IP-clean repository structure

Licensed methods separated from original code, boundaries documented, and a codebase your next investor's diligence reads cleanly.

Grant-aligned phasing

Engagement phases mapped to SBIR objectives with named deliverables, decision logs that feed progress reports, and demo dates on reporting deadlines.

Documentation as product

A docs surface that answers the technical buyer's questions before sales calls do, maintained as scope rather than afterthought.

Pilot machinery

Defined-scope pilot flows, import tooling that skips IT tickets, success-criteria dashboards, and readout reports champions forward.

Deployment, runbook, handoff

Production deployment with monitoring, architecture documentation for your first hire, and an optional maintenance bridge until then.

Built for the Triangle's way of building.

Raleigh-Durham's venture economy runs through its institutions: universities producing spinouts and talent, RTP anchoring enterprise and biotech buyers, and a federal funding pipeline (SBIR, NIH, NSF) that shapes how early companies plan. Founders here are often researchers and engineers first, which makes the substance easy and the commercial urgency the thing to protect.

The buying culture matches: technical evaluators, reference-driven adoption, and loyalty to tools that document well and demo unscripted. We build MVPs for precisely that evaluation, and the artifacts (trials, docs, pilot readouts) are scope, not garnish.

We work with Triangle founders remotely, with weekly working demos on video in Eastern hours and written decisions between them.

Questions from Raleigh-Durham founders.

We are spinning out of a university. What does that change about building the MVP?: Mostly the inputs and the calendar, and both are manageable with eyes open. The inputs: your IP usually arrives through a license from the university's tech-transfer office, and the build should respect its boundaries (what is licensed, what is yours, what remains the lab's) so the codebase never muddies a clean cap table; we keep licensed methods clearly separated from original product code in the repository structure. The calendar: spinouts often run on grant and milestone clocks rather than runway clocks, which suits fixed-scope phases well, and university partners (pilot labs, advisory PIs) move at academic speed, so pilot commitments get calendared early. What does not change: the product still needs a real buyer beyond the founding lab, and we push that question in scoping, because a tool only the home lab loves is a project, not a company.
Our build is partly SBIR-funded. How do grant milestones map to an MVP engagement?: Cleanly, if the scope is written against the milestones from the start. SBIR phases reward exactly what fixed-scope building produces: defined deliverables, demonstrable progress, and documentation. The pattern that works: we map the technical objectives in your Phase I or II workplan to engagement phases with named deliverables (a working prototype for the feasibility aims, measured results for the evaluation aims), keep a written record of design decisions and test results that drops directly into progress reports, and time demos to reporting deadlines so your program officer sees software rather than slides. Two cautions from experience: grant scope and product scope are not identical (the fundable demo and the sellable product overlap but diverge, and we keep both visible), and commercialization sections need real customer evidence, so the MVP should reach pilot users early enough to generate it.
Triangle B2B buyers seem allergic to hype. What does that mean for version one?: It means substance-forward defaults and claims the product can demonstrate on demand. The Triangle's buyer pool skews technical (engineers, scientists, IT leaders at enterprise software and biotech companies), and they respond to: working trials over gated demos (a self-serve sandbox or a pilot on their data beats a choreographed walkthrough), documentation that answers questions before sales calls do, specific numbers with visible methodology rather than superlatives, and integrations that respect their existing stack instead of demanding migration. The MVP supports that motion with a real trial path, honest empty states, admin-grade logging (their IT will look), and a docs page treated as a first-class surface. What this buyer punishes: vague AI claims, 'contact us' pricing at seed stage, and demos that cannot survive an unscripted question. Build for the unscripted question and the Triangle sells itself through references.
We want local pilots: RTP companies, Duke or UNC or NC State labs. How should the MVP court them?: With pilot economics and friction math designed for institutions that have seen many pilots. The package that works locally: a defined pilot scope (one team, one workflow, one quarter) with success criteria written down, pricing that a department can approve without procurement (month-to-month, under the threshold that triggers committee review), onboarding that needs no IT ticket (your product does its own lifting via imports and exports), and a results readout the champion can forward upward. For university labs specifically: respect the academic calendar (pilots that start mid-semester die), expect data-handling questions even for non-sensitive work, and make citation-friendly outputs if the lab might publish with your tool in the methods section, which is quiet marketing gold here. The MVP build includes those artifacts (pilot dashboard, readout report, import tooling) as scope, because in this market the pilot motion is the product's first feature.

Ready to scope your MVP?

Tell us the product, the funding clock, and the pilot you are courting. We reply within one business day with a rough scope and a fixed price range.

SaaS MVP development in Raleigh.

The technical reality of shipping an MVP in the Triangle.

What an MVP engagement includes.

The standard build, tuned for Triangle ventures.

Core workflow, end to end

Next.js, TypeScript, Postgres. The essential loop built completely, with a self-serve trial path as first-class scope.

IP-clean repository structure

Licensed methods separated from original code, boundaries documented, and a codebase your next investor's diligence reads cleanly.

Grant-aligned phasing

Engagement phases mapped to SBIR objectives with named deliverables, decision logs that feed progress reports, and demo dates on reporting deadlines.

Documentation as product

A docs surface that answers the technical buyer's questions before sales calls do, maintained as scope rather than afterthought.

Pilot machinery

Defined-scope pilot flows, import tooling that skips IT tickets, success-criteria dashboards, and readout reports champions forward.

Deployment, runbook, handoff

Production deployment with monitoring, architecture documentation for your first hire, and an optional maintenance bridge until then.

Built for the Triangle's way of building.

We work with Triangle founders remotely, with weekly working demos on video in Eastern hours and written decisions between them.

Questions from Raleigh-Durham founders.

We are spinning out of a university. What does that change about building the MVP?

Mostly the inputs and the calendar, and both are manageable with eyes open. The inputs: your IP usually arrives through a license from the university's tech-transfer office, and the build should respect its boundaries (what is licensed, what is yours, what remains the lab's) so the codebase never muddies a clean cap table; we keep licensed methods clearly separated from original product code in the repository structure. The calendar: spinouts often run on grant and milestone clocks rather than runway clocks, which suits fixed-scope phases well, and university partners (pilot labs, advisory PIs) move at academic speed, so pilot commitments get calendared early. What does not change: the product still needs a real buyer beyond the founding lab, and we push that question in scoping, because a tool only the home lab loves is a project, not a company.

Our build is partly SBIR-funded. How do grant milestones map to an MVP engagement?

Cleanly, if the scope is written against the milestones from the start. SBIR phases reward exactly what fixed-scope building produces: defined deliverables, demonstrable progress, and documentation. The pattern that works: we map the technical objectives in your Phase I or II workplan to engagement phases with named deliverables (a working prototype for the feasibility aims, measured results for the evaluation aims), keep a written record of design decisions and test results that drops directly into progress reports, and time demos to reporting deadlines so your program officer sees software rather than slides. Two cautions from experience: grant scope and product scope are not identical (the fundable demo and the sellable product overlap but diverge, and we keep both visible), and commercialization sections need real customer evidence, so the MVP should reach pilot users early enough to generate it.

Triangle B2B buyers seem allergic to hype. What does that mean for version one?

It means substance-forward defaults and claims the product can demonstrate on demand. The Triangle's buyer pool skews technical (engineers, scientists, IT leaders at enterprise software and biotech companies), and they respond to: working trials over gated demos (a self-serve sandbox or a pilot on their data beats a choreographed walkthrough), documentation that answers questions before sales calls do, specific numbers with visible methodology rather than superlatives, and integrations that respect their existing stack instead of demanding migration. The MVP supports that motion with a real trial path, honest empty states, admin-grade logging (their IT will look), and a docs page treated as a first-class surface. What this buyer punishes: vague AI claims, 'contact us' pricing at seed stage, and demos that cannot survive an unscripted question. Build for the unscripted question and the Triangle sells itself through references.

We want local pilots: RTP companies, Duke or UNC or NC State labs. How should the MVP court them?

With pilot economics and friction math designed for institutions that have seen many pilots. The package that works locally: a defined pilot scope (one team, one workflow, one quarter) with success criteria written down, pricing that a department can approve without procurement (month-to-month, under the threshold that triggers committee review), onboarding that needs no IT ticket (your product does its own lifting via imports and exports), and a results readout the champion can forward upward. For university labs specifically: respect the academic calendar (pilots that start mid-semester die), expect data-handling questions even for non-sensitive work, and make citation-friendly outputs if the lab might publish with your tool in the methods section, which is quiet marketing gold here. The MVP build includes those artifacts (pilot dashboard, readout report, import tooling) as scope, because in this market the pilot motion is the product's first feature.

Ready to scope your MVP?

Tell us the product, the funding clock, and the pilot you are courting. We reply within one business day with a rough scope and a fixed price range.